"10.1371_journal.pone.0095558","plos one","2014-04-23T00:00:00Z","Fruzsina Soltész; John Suckling; Phil Lawrence; Roger Tait; Cinly Ooi; Graham Bentley; Chris M Dodds; Sam R Miller; David R Wille; Misha Byrne; Simon M McHugh; Mark A Bellgrove; Rodney J Croft; Bai Lu; Edward T Bullmore; Pradeep J Nathan","Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom; Brain Mapping Unit, Department of Psychiatry, University of Cambridge, United Kingdom; Department of Psychology, University of Exeter, Exeter, United Kingdom; Queensland Brain Institute, University of Queensland, Queensland, Australia; School of Psychology and Psychiatry, Monash University, Melbourne, Australia; Tsinghua University Medical School, Beijing, China; New Medicines, UCB Pharma, Brussels, Belgium","Conceived and designed the experiments: PJN ETB BL. Performed the experiments: PL GB RT CO JS CMD. Analyzed the data: FS RT CO JS PL GB. Contributed reagents/materials/analysis tools: MAB MB RJC SM. Wrote the paper: FS PJN JS. statistical support and tools: SRM DRW.","FS, PL, GB, SRM, DRW & SMH are employees of GlaxoSmithKline, whose company funded this study. PJN is an employee of UCB Pharma. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","04","Fruzsina Soltész","FS",16,TRUE,3,6,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
